SCHEMBL17179783

SCHEMBL17179783

COc1ccc(C2Oc3cc(O[3CH3])cc(O[3CH3])c3C(=O)C2O)cc1OC

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.79
▸ XDH P47989 2/20 0.63
▸ ABCB1 P08183 5/20 0.49
▸ MAPT P10636 4/20 0.48
▸ HPGD P15428 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ AGTR1 P30556 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ CYP2C9 P11712 4/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ ALOX15 P16050 3/20 0.46
▸ SLCO1B3 Q9NPD5 3/20 0.46
▸ SLCO1B1 Q9Y6L6 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ SLCO2B1 O94956 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17179811 0.89 ALDH1A1 (1.00) ALDH1A1XDHABCB1MAPTHPGD
SCHEMBL28024600 0.81 ALDH1A1 (0.78) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL31162964 0.80 ALDH1A1 (0.71) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL19789557 0.78 XDH (0.70) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL16942322 0.78 ALDH1A1 (0.76) ALDH1A1XDHABCB1
SCHEMBL10608985 0.77 ALDH1A1 (0.67) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL28545861 0.76 ALDH1A1 (0.78) ALDH1A1XDHABCB1HPGDKDM4E
SCHEMBL28213500 0.75 ALDH1A1 (0.71) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL28302550 0.75 ALDH1A1 (0.71) ALDH1A1XDHMAPTHPGDKDM4E
SCHEMBL23202794 0.74 ALDH1A1 (0.62) ALDH1A1XDHMAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291547-A1 SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF NANYANG POLYTECHNIC (SG) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291547-A1 SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF TERT, POT1, TERF2 ALDH1A1 2026/4885XDH 2934/4885ABCB1 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback